Top 10 HealthCare Devices and Supplies Capital Raises in the U.S. – June 1st – 15th, 2025
Several interesting transactions closed in the HealthCare Devices and Supplies sector over the past two weeks. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
PE Growth/Expansion
- Vascular Technology, surgical devices intended for multiple specialties, such as vascular, reconstructive, urology, GI endoscopy, neurosurgery, and robotic surgery, received a development capital from JLL Partners.
- Wellvii, fitness tracking devices intended to increase efficiency and quality of healthcare using non-invasive vital sign measurement sensor technology, received development capital from Shift4 Capital.
Merger/Acquisition
- AllAccem, veterinary dermatology and dental care products intended to support animal health and hygiene, acquired by Vimian Group.
Later Stage VC
- Accelus, medical implants designed to focus on expandable interbody technology for spine surgery, raised $6.08 million of venture funding in a deal led by Concord Health Partners.
- AmplifiDX, molecular point-of-care device designed to provide rapid test results in a cost-effective way, raised venture funding from Femovate.
Early Stage VC
- Centrus Diagnostics, wearable health monitoring medical technology intended to improve the diagnosis and management of cardiovascular diseases, raised $1.68 million of Series A1 venture funding.
- Curve Biosciences, liver cancer diagnostics designed for disease prevention and screening, raised venture funding from First Spark Ventures.
Seed Round
- Somnee, a diagnostic and therapeutic wearable technology designed to improve sleep quality and efficiency and create better sleep through neuroscience, raised $23 million of seed funding in a deal led by Khosla Ventures.
- Cosm Medical, a digital platform designed to personalize care for pelvic health issues affecting women, raised seed+ funding in a deal led by iGan Partners.
- Origin Endoscopy, endoscopy products designed to control gastrointestinal bleeding, raised $2.34 million through the combination of Seed-1, Seed-2 and Seed-3 funding from Highpoint Ventures, Innosphere Ventures and other investors.
#castleplacement #capitalraising #privateequity #venturecapital #investment #healthcaredevicesandsupplies #healthcaredevice #healthcaresupplies
Tamara Williams
Managing Director
15+ years of experience in investment banking and financial structuring including private equity, acquisitions, fund management and raising debt capital within various sectors including real estate, oil and gas, hospitality, serviced offices, IT and trading. Advised on investment opportunities, capital structure, holding and tax structure. Skilled at conducting due diligence, company valuation and providing real estate development project oversight. International network extending from the US, UK, France, Russia, and the Middle East to Asia. Previously held several senior management positions in the financial industry. Master of Business Administration with Distinction from the University of Northampton UK. Higher National Diploma with Distinction from ABE UK. FINRA Series 7, 79, and 66 licenses.
- twilliams@castleplacement.com
- (385) 600-1871
 Tamara WilliamsManaging Director |
Please contact me if you have any questions or would like to discuss your capital raise:
Email: twilliams@castleplacement.com
(C) (385) 600-1871
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement™ does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
